A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low Expression
Convalife (Shanghai) Co., Ltd.
Convalife (Shanghai) Co., Ltd.
Kaiser Permanente
Weill Medical College of Cornell University
Anhui Provincial Hospital
Tasly Biopharmaceuticals Co., Ltd.
Peking Union Medical College Hospital
Convalife (Shanghai) Co., Ltd.
SCG Cell Therapy Pte. Ltd.
Corregene Biotechnology Co., Ltd
Charite University, Berlin, Germany